AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
- 1 April 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (4) , 340-351
- https://doi.org/10.1038/nrd1344
Abstract
No abstract availableKeywords
This publication has 152 references indexed in Scilit:
- The central role of fat and effect of peroxisome proliferator-activated receptor–γ on progression of insulin resistance and cardiovascular diseaseThe American Journal of Cardiology, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- The Transcription Factor SREBP-1c Is Instrumental in the Development of औ-Cell DysfunctionPublished by Elsevier ,2003
- Inflammation in atherosclerosisNature, 2002
- Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?Trends in Molecular Medicine, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Insulin and Contraction Directly Stimulate UCP2 and UCP3 mRNA Expression in Rat Skeletal Muscle in VitroBiochemical and Biophysical Research Communications, 2001
- AMP‐activated protein kinase phosphorylation of endothelial NO synthaseFEBS Letters, 1999
- Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.Journal of Clinical Investigation, 1995